Skip to content

Fructose Supplementation in Carriers for Hereditary Fructose Intolerance

Metabolic Effects of Short-term Dietary Supplementation With Fructose in Carriers for Hereditary Fructose Intolerance

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03545581
Enrollment
12
Registered
2018-06-04
Start date
2018-05-01
Completion date
2019-04-01
Last updated
2019-04-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hereditary Fructose Intolerance

Keywords

Fructose, Uric acid, Glucose homeostasis

Brief summary

This study aimed to examine metabolic response to a short-term fructose enriched diet in carriers for hereditary fructose intolerance compared to controls. Effects of fructose coffees will be assessed in 7 healthy volunteers and 7 subjects with heterozygous mutation for ALDOB gene in a randomized, controlled, crossover trial.

Detailed description

A high fructose intake also increases blood lactate and uric acid concentrations. It has been proposed that uric acid may contribute to insulin resistance by impairing endothelium-dependent vasodilation, promoting pro-inflammatory effects and dyslipidemia by activating de novo lipogenesis. These consequences of fructose overconsumption may be even more marked in individuals with hereditary alterations in fructose metabolism. Indeed, individuals with hereditary fructose intolerance (HFI), due to biallelic mutations in the gene coding for aldolase B (ALDOB), may develop acute, life-threatening manifestations when exposed to fructose. Heterozygous carriers of ALDOB mutation are quite common in the general population, with a predicted frequency ranging between 1:55 and 1:120. Few studies have examined the effect of fructose ingestion in heterozygotes subject for HFI. Heterozygous carriers are generally considered to have normal fructose metabolism since a \ 50% level of aldolase B activity is presumed to be sufficient for adequate function. However, heterozygous carriers were reported to have enhanced uric acid responses to large intravenous and/or oral fructose loads. Investigators hypothesized that heterozygous carriers may also have mild defects of fructose metabolism and/or a larger increase in cardiometabolic risk factors than the normal population after ingestion of moderate amounts of fructose.

Interventions

OTHERExperimental diet Fru rich diet

7 days (day 1 to day 7) with fructose enriched drinks 3x/d. Test meal at day 7 with fructose (0.7 g/body weight) and glucose (0.7 g/body weight)

OTHERExperimental low Fru diet

7 days (day 1 to day 7) with low-fructose diet (\<10g/d). Test meal at day 7 with fructose (0.7 g/body weight) and glucose (0.7 g/body weight)

Sponsors

University of Liege
CollaboratorOTHER
University of Lausanne
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
Yes

Inclusion criteria

* Case subjects: Heterozygous carriers for ALDOB mutation confirmed by molecular analysis * Control subjects: healthy individuals matched for weight and age to subjects

Exclusion criteria

* Fasting glucose \> 7.0 mmol/L * Fasting triglycerides \> 4.0 mmol/L * Chronic renal insufficiency (eGFR \< 50 ml/min) * Drugs * Women who are pregnant or breast feeding * For women: lack of safe contraception * Alcool consumption \> 30g/d * Inability to discern

Design outcomes

Primary

MeasureTime frameDescription
Metabolite concentrationTime Frame: -30 min before ingestion of a test meal to 120 min after ingestion of a test mealThe primary endpoint is the change of metabolite concentration after ingestion of a test meal (oral glucose and fructose load) under 2 conditions (enriched fructose diet vs poor fructose diet) according to a crossover design

Secondary

MeasureTime frameDescription
Plasma insulin concentrationTime Frame: -30 min before ingestion of a test meal to 120 min after ingestion of a test mealChange in insulin concentration after ingestion of a test meal under 2 conditions (enriched fructose diet vs poor fructose diet) according to a crossover design
Plasma fructose concentrationTime Frame: -30 min before ingestion of a test meal to 120 min after ingestion of a test mealChange in fructose concentration after ingestion of a test meal under 2 conditions (enriched fructose diet vs poor fructose diet) according to a crossover design
Plasma uric acid concentrationTime Frame: -30 min before ingestion of a test meal to 120 min after ingestion of a test mealChange in uric acid concentration after ingestion of a test meal under 2 conditions (enriched fructose diet vs poor fructose diet) according to a crossover design
Plasma lactate concentrationTime Frame: -30 min before ingestion of a test meal to 120 min after ingestion of a test mealChange in lactate concentration after ingestion of a test meal under 2 conditions (enriched fructose diet vs poor fructose diet) according to a crossover design
Plasma urea concentrationTime Frame: -30 min before ingestion of a test meal to 120 min after ingestion of a test mealChange in urea concentration after ingestion of a test meal under 2 conditions (enriched fructose diet vs poor fructose diet) according to a crossover design
Plasma creatinine concentrationTime Frame: -30 min before ingestion of a test meal to 120 min after ingestion of a test mealChange in creatinine concentration after ingestion of a test meal under 2 conditions (enriched fructose diet vs poor fructose diet) according to a crossover design
Plasma phosphate concentrationTime Frame: -30 min before ingestion of a test meal to 120 min after ingestion of a test mealChange in phosphate concentration after ingestion of a test meal under 2 conditions (enriched fructose diet vs poor fructose diet) according to a crossover design
Plasma triglycerides concentrationTime Frame: -30 min before ingestion of a test meal to 120 min after ingestion of a test mealChange in triglycerides concentration after ingestion of a test meal under 2 conditions (enriched fructose diet vs poor fructose diet) according to a crossover design
Plasma metabolome concentrationTime Frame: -30 min before ingestion of a test meal to 120 min after ingestion of a test mealChange in metabolome concentration after ingestion of a test meal under 2 conditions (enriched fructose diet vs poor fructose diet) according to a crossover design
Plasma glucose concentrationTime Frame: -30 min before ingestion of a test meal to 120 min after ingestion of a test mealChange in glucose concentration after ingestion of a test meal under 2 conditions (enriched fructose diet vs poor fructose diet) according to a crossover design
Plasma amino acid concentrationTime Frame: -30 min before ingestion of a test meal to 120 min after ingestion of a test mealChange in amino acid concentration after ingestion of a test meal under 2 conditions (enriched fructose diet vs poor fructose diet) according to a crossover design
Plasma alanine transaminase (ALAT) concentrationTime Frame: -30 min before ingestion of a test meal to 120 min after ingestion of a test mealChange in alanine transminase (ALAT) concentration after ingestion of a test meal under 2 conditions (enriched fructose diet vs poor fructose diet) according to a crossover design
Plasma aspartate transaminase (ASAT) concentrationTime Frame: -30 min before ingestion of a test meal to 120 min after ingestion of a test mealChange in aspartate transaminase (ASAT) concentration after ingestion of a test meal under 2 conditions (enriched fructose diet vs poor fructose diet) according to a crossover design
Urine metabolome concentrationTime Frame: 24 hour urine collection before ingestion of a test meal and after 7 days of 2 conditions (enriched fructose diet vs poor fructose diet) according to a crossover designChange in urine metabolome profile after low fructose diet and an enriched fructose diet according to a crossover design
Urine creatinine concentrationTime Frame: 24 hour urine collection before ingestion of a test meal and after 7 days of 2 conditions (enriched fructose diet vs poor fructose diet) according to a crossover designChange in urine creatinine profile after low fructose diet and an enriched fructose diet according to a crossover design
Urine urea concentrationTime Frame: 24 hour urine collection before ingestion of a test meal and after 7 days of 2 conditions (enriched fructose diet vs poor fructose diet) according to a crossover designChange in urine urea profile after low fructose diet and an enriched fructose diet according to a crossover design
Urine uric acid concentrationTime Frame: 24 hour urine collection before ingestion of a test meal and after 7 days of 2 conditions (enriched fructose diet vs poor fructose diet) according to a crossover designChange in urine uric acid profile after low fructose diet and an enriched fructose diet according to a crossover design
Body weightTime Frame: at baseline before study intervention and at the end of each conditions (enriched fructose diet vs poor fructose diet) according to a crossover designChange of body weight after low fructose diet and an enriched fructose diet according to a crossover design
Blood pressureTime Frame: at baseline before study intervention and at the end of each conditions (enriched fructose diet vs poor fructose diet) according to a crossover designChange of systolic and diastolic pressure after low fructose diet and an enriched fructose diet according to a crossover design
Plasma ammonia concentrationTime Frame: -30 min before ingestion of a test meal to 120 min after ingestion of a test mealChange in ammonia concentration after ingestion of a test meal under 2 conditions (enriched fructose diet vs poor fructose diet) according to a crossover design

Countries

Belgium

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 16, 2026